OPERF
CPRX

Oregon Public Employees Retirement Fund’s Catalyst Pharmaceutical CPRX Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$821K Sell
26,128
-300
-1% -$8.85K 0.01% 1032
2026
Q1 		$654K Hold
26,428
– – 0.01% 1071
2025
Q4 		$617K Buy
26,428
+472
+2% +$10.5K 0.01% 1081
2025
Q3 		$511K Sell
25,956
-100
-0.4% -$2.06K 0.01% 1135
2025
Q2 		$565K Buy
26,056
+417
+2% +$9.84K 0.01% 1064
2025
Q1 		$622K Sell
25,639
-705
-3% -$15.9K 0.01% 1015
2024
Q4 		$550K Buy
26,344
+100
+0.4% +$2.15K 0.01% 1110
2024
Q3 		$522K Sell
26,244
-1,000
-4% -$18.5K 0.01% 1137
2024
Q2 		$422K Sell
27,244
-2,700
-9% -$42K 0.01% 1185
2024
Q1 		$477K Buy
29,944
+600
+2% +$9.04K 0.01% 1171
2023
Q4 		$493K Sell
29,344
-415
-1% -$5.67K 0.01% 1212
2023
Q3 		$348K Sell
29,759
-600
-2% -$8.03K ﹤0.01% 1413
2023
Q2 		$408K Sell
30,359
-400
-1% -$5.76K ﹤0.01% 1387
2023
Q1 		$510K Sell
30,759
-1,080
-3% -$17.8K 0.01% 1284
2022
Q4 		$592K Buy
31,839
+211
+0.7% +$3.25K 0.01% 1230
2022
Q3 		$406K Buy
+31,628
New +$375K 0.01% 1342

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Oregon Public Employees Retirement Fund's CPRX Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund reduced its Catalyst Pharmaceutical (CPRX) stake by 1.1% in Q2 2026, selling an estimated $8.85K and leaving 26,128 shares worth $821K. The position accounts for 0.01% of the portfolio, ranked #1032.

Oregon Public Employees Retirement Fund first reported a position in CPRX in Q3 2022 and has held it in 16 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Oregon Public Employees Retirement Fund held 26,128 shares of Catalyst Pharmaceutical worth $821K as of Q2 2026.
  • Oregon Public Employees Retirement Fund sold 300 Catalyst Pharmaceutical shares in Q2 2026, an estimated $8.85K.
  • Catalyst Pharmaceutical made up 0.01% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #1032 holding.
  • Oregon Public Employees Retirement Fund first reported a position in Catalyst Pharmaceutical in Q3 2022 and has held it in 16 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.